We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$151M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$48.3M
3
ITOS
iTeos Therapeutics
ITOS
+$21.3M
4
QNGY
Quanergy Systems, Inc.
QNGY
+$11.5M
5
FULC icon
Fulcrum Therapeutics
FULC
+$10.9M

Top Sells

Rank Stock Value
1
SMH icon
VanEck Semiconductor ETF
SMH
+$30.8M
2
DIS icon
Walt Disney
DIS
+$23.1M
3
NGHC
National General Holdings Corp
NGHC
+$20.7M
4
STLA icon
Stellantis
STLA
+$19.7M
5
SVOKU
Seven Oaks Acquisition Corp. Unit
SVOKU
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTAC.WS
426
DELISTED
Cerberus Telecom Acquisition Corp. Warrants included as part of the Units, each whole warrant exerci
CTAC.WS
$31K ﹤0.01%
+29,806
New +$48.1K
MIST icon
427
Milestone Pharmaceuticals
MIST
$158M
$30K ﹤0.01%
+5,166
New +$37.8K
PCVX icon
428
CALL
Vaxcyte
PCVX
$8.81B
$30K ﹤0.01%
+15,000
New +$377K
UKOMW
429
DELISTED
Ucommune International Ltd Warrant
UKOMW
$30K ﹤0.01%
80,000
– –
FGNA.WS
430
DELISTED
FG New America Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FGNA.WS
$30K ﹤0.01%
19,462
-30,538
-61% -$51.6K
CNST
431
PUT
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$30K ﹤0.01%
+29,700
New +$900K
OPEN icon
432
PUT
Opendoor
OPEN
$3.48B
$29K ﹤0.01%
+10,333
New +$273K
HGEN
433
CALL
DELISTED
HUMANIGEN, INC.
HGEN
$29K ﹤0.01%
+15,200
New +$277K
NBIX icon
434
CALL
Neurocrine Biosciences
NBIX
$16.5B
$28K ﹤0.01%
6,500
-6,000
-48% -$629K
RDBXW
435
DELISTED
Redbox Entertainment Inc. Warrant
RDBXW
$28K ﹤0.01%
50,100
+35,100
+234% +$34.4K
VYGG.WS
436
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$27K ﹤0.01%
13,500
-86,500
-87% -$234K
YSAC.WS
437
DELISTED
Yellowstone Acquisition Company Warrants, each whole warrant exercisable for one share of Class A co
YSAC.WS
$27K ﹤0.01%
29,723
-40,877
-58% -$52.2K
FCX icon
438
CALL
Freeport-McMoran
FCX
$96.4B
$26K ﹤0.01%
+10,000
New +$324K
TLSIW icon
439
TriSalus Life Sciences Warrant
TLSIW
$38.7M
$26K ﹤0.01%
+23,440
New +$42.3K
HIGA.WS
440
DELISTED
H.I.G. Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HIGA.WS
$26K ﹤0.01%
+25,000
New +$36.8K
NBA.WS
441
DELISTED
New Beginnings Acquisition Corp. Redeemable Warrants, each warrant exercisable for one share of Comm
NBA.WS
$26K ﹤0.01%
39,236
+14,236
+57% +$13.9K
HALO icon
442
PUT
Halozyme
HALO
$11.6B
$25K ﹤0.01%
+25,000
New +$1.14M
XBI icon
443
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$25K ﹤0.01%
8,500
-41,100
-83% -$6.15M
FTCH
444
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$24K ﹤0.01%
+29,800
New +$1.82M
EUSGW
445
DELISTED
European Sustainable Growth Acquisition Corp. Warrant
EUSGW
$24K ﹤0.01%
+39,836
New +$35.4K
NTRA icon
446
PUT
Natera
NTRA
$45.1B
$23K ﹤0.01%
+22,800
New +$2.5M
STLNW
447
Starling Oncology, Inc. Warrant
STLNW
$4.99M
$22K ﹤0.01%
16,000
+5,710
+55% +$10.6K
GME icon
448
GameStop
GME
$8.44B
$21K ﹤0.01%
+444
New +$13.1K
MAT icon
449
Mattel
MAT
$4.29B
$21K ﹤0.01%
+1,030
New +$19.9K
MIST icon
450
PUT
Milestone Pharmaceuticals
MIST
$158M
$21K ﹤0.01%
+8,700
New +$63.7K
16 17
18
19 20

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.